MarketPeel
Chief Commercial Officer
Tue, Jul 21, 2026
Jul 21
sold $199.89k of MLYS
7,438 shares @ $26.87
Decreased holdings by -16.20%
Net across this filing: 0.00% (+0 shares)
3rd largest trade (out of 38)
Planned (10b5-1)
These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
59% win rate · +19.1% median edge vs SPY (27 trades, 90-day)
Price 14% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
MLYSMineralys Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W-1.54%
1M-3.97%
3M-14.47%
6M
1Y

Recent insider activity at MLYS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback